History

2011
			CodeXyme^® cellulase enzymes introduced
			Raízen collaboration for first generation ethanol announced
			CodeXol^® detergent alcohols product line introduced
			Chemtex detergent alcohols collaboration announced
			First cellulase enzymes produced at commercial scale
			Teva development milestones achieved
			Alcoa carbon capture commercial agreement announced
			Carbon capture progress announced at ARPA-E Summit
			Former Senator Dorgan elected to Board
			First Japanese pharma collaboration signed
			Enzyme supply agreement with DSM
			Draper Prize awarded to early directed evolution pioneers
2010
			Carbon capture collaboration with Alstom
			Maxygen directed evolution IP portfolio acquired
			Codex^® Screening Kits introduced
			U.S. EPA Presidential Green Chemistry Challenge Award with Merck
			Science paper on sitagliptin process published with Merck
			ARPA-E grant awarded for carbon capture clean air technology
			Codexis IPO on April 22
			Pharma manufacturing partnerships expanded
2009
			Codex^® Panels agreement with Roche
			Further expanded Shell biofuels collaboration
			Licensing agreement with Teva
2008
			Expanded collaboration with Arch Pharmalabs, India
			Codexis Laboratories Hungary opened
2007
			Extended Shell biofuels collaboration to broad, 5 year program
			Codexis Laboratories Singapore opened
			Acquisition of BioCatalytics
			Collaboration signed with Merck
			Important research results published in Nature Biotechnology
			Codex^® Biocatalyst Panels Introduced
2006
			Shell collaboration in biofuels
			Direct sale of generic pharmaceutical intermediates begun
			Collaboration signed with Schering-Plough
			U.S. EPA's Presidential Green Chemistry Challenge Award
2005
			Collaborations signed with Bristol-Myers Squibb, Arch
			European expansion with acquisition of Jülich Fine Chemicals, Germany
2004
			Collaborations signed with Pfizer, Teva, Lonza
2003
			Collaborations signed with Sandoz, Cargill
2002
			Codexis incorporated, launches operations